US 10675245
Sustained release formulation of a non-steroidal anti-inflammatory drug
granted A61KA61K31/196A61K31/407
Quick answer
US patent 10675245 (Sustained release formulation of a non-steroidal anti-inflammatory drug) held by Pacira Pharmaceuticals, Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pacira Pharmaceuticals, Inc.
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/196, A61K31/407, A61K31/5415, A61K9/127